Intellia Therapeutics
Tiffany L. has a strong background in analytical development with extensive experience in the biotechnology sector. Currently serving as a Scientist at Intellia Therapeutics, Inc., since August 2019, Tiffany has progressed through various roles including Senior Associate Scientist and Associate Scientist. Prior experience includes a tenure at Gilead Sciences where Tiffany held several positions in analytical development from September 2015 to July 2019, culminating as Senior Research Associate II. Tiffany began professional experience as a Research Assistant at McGill University in early 2008, focusing on phenotypic differences in lung carcinoma cells. Academic qualifications include a Master of Science in Chemical Biology with a specialization in Protein Engineering from the University of Alberta, along with a Bachelor of Science (Honours) in Biochemistry from McGill University.
This person is not in the org chart
This person is not in any teams
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.